P&G Health Revenue **20.7%** Bhaga, Par Profit Mein Giraavat! Dividend Kitna Mila?

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorAnanya Iyer|Published at:
P&G Health Revenue **20.7%** Bhaga, Par Profit Mein Giraavat! Dividend Kitna Mila?
Overview

Yaar, P&G Health ne Q3 mein revenue toh **20.7%** bhaga diya, poora **₹37,386 lakh** kamaya. Lekin bhai, expenses **40.3%** badh gaye, jis se profit **14.6%** neeche aa gaya, sirf **₹7,759 lakh** raha. Phir bhi, shareholders ke liye **₹160** ka tagda interim dividend declare kiya hai!

P&G Health ke Q3 FY26 Results: Kya Hua Asal Mein?

Bhai log, Procter & Gamble Health Limited ne apne Q3 FY26 ke results announce kiye hain, aur numbers mein thoda mix hai. Company ne sales mein to kamaal kar diya, revenue 20.7% badha kar ₹37,386 lakh tak pahuncha diya. Ye pichle saal ke ₹30,977 lakh se kaafi zyada hai. Quarter-on-quarter bhi 15.05% ka growth dikhaya hai.

Profit Ka Kya Scene Hai?

Lekin yaar, jab profit ki baat aayi toh thodi gadbad ho gayi. Net profit 14.6% gir kar ₹7,759 lakh par aa gaya, jo pichle saal ₹9,090 lakh tha. Quarter-on-quarter bhi 12.38% ka drop aaya hai. Iska sabse bada reason hai expenses ka 40.3% badh jaana. Jab kharche itne badh jaate hain toh profit margins par pressure aata hi hai.

Is wajah se, PBT margin 38.79% se gir kar 28.77% ho gaya, aur Net Profit margin bhi 28.97% se 20.51% par aa gaya. Yani, kamaai toh badhi, par jeb mein rakhne wale paisa ghata.

9 Mahine Ka Performance Aur Dividend!

Agar 9 mahine ki baat karein toh net profit 22.26% badha hai, lekin yeh growth pichle saal ke kuch exceptional items ke na hone ki wajah se zyada lag raha hai. Pichle saal ₹2,019 lakh ka exceptional item tha jo Goa plant ke disposal se related tha.

Sabse achhi khabar shareholders ke liye yeh hai ki company ke Board ne ₹160 per share ka interim dividend declare kiya hai, jisme ₹50 ka special dividend bhi shamil hai. Ye ek achhi khabar hai, unke liye jo stock hold karte hain.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.